Critical Organ Preservation in Reirradiation Brachytherapy by Injectable Spacer

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 2, 2009, Pages 587-594

  Kishi, Kazushi ^a   Sonomura, Tetsuo ^a   Shirai, Shintaro ^a   Sato, Morio ^a   Tanaka, Kayo ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brachytherapy; High dose rate; Hyaluronic acid; Normal tissue complication probability (NTCP); Reirradiation

Indexed keywords

BRACHYTHERAPY; HIGH-DOSE RATE; HYALURONIC ACID; NORMAL TISSUE COMPLICATION PROBABILITY (NTCP); REIRRADIATION;

GELATION; ORGANIC ACIDS; TUMORS;

RISKS;

HYALURONIC ACID;

ABDOMINAL WALL; ADULT; AGED; ARTICLE; AXILLA; BREAST; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GEL; HUMAN; INTERSTITIAL RADIATION; MALE; PAIN; PELVIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION SAFETY; RECURRENT CANCER; SKELETON; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRACHYTHERAPY; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; GELS; HEAD AND NECK NEOPLASMS; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAIN, INTRACTABLE; PROBABILITY; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REMISSION INDUCTION; RETREATMENT; SKIN NEOPLASMS; TUMOR BURDEN;

EID: 69549110104     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.03.072     Document Type: Article

References (26)

1. Hayashi S., Hoshi H., and Iida T. Reirradiation with local-field radiotherapy for painful bone metastases. Radiat Med 20 5 (2002) 231-236
2. Okamoto Y., et al. Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys 52 2 (2002) 390-396
3. Wu S.X., et al. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 69 3 (2007) 761-769
4. Salama J.K., et al. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 64 2 (2006) 382-391
5. Joseph K.J., et al. Reirradiation after radical radiation therapy: A survey of patterns of practice among Canadian radiation oncologists. Int J Radiat Oncol Biol Phys 72 (2008) 1523-1529
6. Kishi K, Adati H, Takada K, inventors. Implants for radiation therapy. In: Editor, Patent publication bulletin. J.P. Office. Kuraray Medical: Japan; 2004 Month Day.
7. Kishi K., et al. Brachytherapy technique for abdominal wall metastases of colorectal cancer: ultrasound-guided insertion of applicator needle and a skin preservation method. Acta Radiol 47 2 (2006) 157-161
8. Kishi K, et al. Preservation of risk organs in critical brachytherapy by tissue spacing with percutaneous injection. Presented at the 5th Annual Japan-US Cancer Therapy Symposium and the 5th Annual S. Takahashi Memorial Joint Symposium, September 7, 2007, Sendai, Japan.
9. Kishi K., et al. Computer-aided preservation of risk organs in critical brachytherapy by tissue spacing with percutaneous injection of hyaluronic acid solution. Int J Radiat Oncol Biol Phys 69 3 (2007) S568-S569
10. Dover J.S., et al. Clinical use of RESTYLANE. Skin Therapy Lett 10 1 (2005) 5-7
11. Emami B., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 1 (1991) 109-122
12. Burman C., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 1 (1991) 123-135
13. Burman C.M. Fitting of tissue tolerance data to analytic function: Improving the therapeutic ratio. Front Radiat Ther Oncol 37 (2002) 151-162
14. Brenner D.J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18 4 (2008) 234-239
15. Kirkpatrick J.P., Meyer J.J., and Marks L.B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 18 4 (2008) 240-243
16. Prada P.J., et al. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients. Int J Radiat Oncol Biol Phys 69 1 (2007) 95-102
17. Arron S.T., and Neuhaus I.M. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid. Journal of Cosmetic Dermatology 6 3 (2007) 167-171
18. Sulman E.P., Schwartz D.L., Le I.I., et al. IMRT reirradiation of head and neck cancer: Disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 73 (2008) 399-409
19. Wurschmidt F., et al. Reirradiation of recurrent breast cancer with and without concurrent chemotherapy. Radiat Oncol 3 (2008) 28
20. Oksuz D.C., et al. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 60 2 (2004) 388-394
21. McQuestion M. Evidence-based skin care management in radiation therapy. Semin Oncol Nurs 22 3 (2006) 163-173
22. Primavera G., et al. A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis. Cutaneous and Ocular Toxicology 25 3 (2006) 165-171
23. Kusunoki M., et al. Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: A prospective randomized clinical trial. Surg Today 35 11 (2005) 940-945
24. Restylane International. Restylane. http://www.restylane.com/Templates/Page.aspx?id=1775. 2008.
25. Hamilton R., Strobos J., and Adkinson N. Immunogenicity studies of cosmetically administered nonanimal-stabilized hyaluronic acid particles. Dermatologic Surgery 33 Suppl 2 (2007) S176-S185
26. Vordermark D., et al. Transperineal Injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: In regard to Prada, et al. Int J Radiat Oncol Biol Phys 71 1 (2008) 316-317